Metastatic Melanoma in Young Child.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
20
04
2022
accepted:
15
02
2023
medline:
30
10
2023
pubmed:
8
4
2023
entrez:
7
4
2023
Statut:
ppublish
Résumé
Pediatric melanoma is a rare cancer, especially in young children, and it remains a diagnostic challenge. We report a case of massively metastatic melanoma in young patient with an atypical clinical and biological presentation and with no risk factors.
Identifiants
pubmed: 37027236
doi: 10.1097/MPH.0000000000002663
pii: 00043426-202311000-00005
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-462Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Cahn F, Revon-Riviere G, Min V, et al. Blood-derived liquid biopsies using Foundation One ® liquid CDx for children and adolescents with high-risk malignancies: a monocentric experience. Cancers (Basel). 2022;14:2774.
Berlanga P, Pierron G, Lacroix L, et al. The European MAPPYACTS Trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies. Cancer Discov. 2022;12:1266–1281.
Merkel EA, Mohan LS, Shi K, et al. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis. Lancet Child Adolesc Health. 2019;3:646–654.
Kaste SC. Imaging of pediatric cutaneous melanoma. Pediatr Radiol. 2019;49:1476–1487.
Xing Y, Bronstein Y, Ross MI, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103:129–142.
Pfannenberg C, Aschoff P, Schanz S, et al. Prospective comparison of 18Ffluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43:557–564.
Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment—Update 2019. Eur J Cancer. 2020;126:159–177.
Que Y, Hu Y, Hong D, et al. Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov. J Immunother Cancer. 2021;9:e002920.